头蛋白(NOG)检测试剂盒(酶联免疫吸附试验法)
ELISA Kit for Noggin (NOG)
SYM1; SYNS1; Synostoses(Multiple)Syndrome 1; Symphalangism 1(Proximal)
- 编号SEC130Hu
 - 物种Homo sapiens (Human,人)相同的名称,不同的物种。
 - 实验方法双抗夹心
 - 反应时长3h
 - 检测范围15.6-1,000ng/mL
 - 灵敏度最小可检测剂量小于等于5.6ng/mL.
 - 样本类型serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
 - 下载英文说明书 中文说明书
 - 规格48T96T96T*596T*1096T*100
 - 价格¥ 2940¥ 4200¥ 18900¥ 35700¥ 294000
 - 欲了解实际交易价格和更多情况,请与当地经销商联系!
 
特异性
                        本试剂盒用于检测头蛋白(NOG),经检测与其它相似物质无明显交叉反应。
                        由于受到技术及样本来源的限制,不可能完成对所有相关或相似物质交叉反应检测,因此本试剂盒有可能与未经检测的其它物质有交叉反应。
                    
回收率
分别于定值血清及血浆样本中加入一定量的头蛋白(NOG)(加标样品),重复测定并计算其均值,回收率为测定值与理论值的比率。
| 样本 | 回收率范围(%) | 平均回收率(%) | 
| serum(n=5) | 82-102 | 87 | 
| EDTA plasma(n=5) | 89-97 | 94 | 
| heparin plasma(n=5) | 89-103 | 94 | 
精密度
                    精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100 
                    批内差:取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次,分别计算不同浓度样本的平均值及SD值。
                    批间差:选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定,每个样本使用同一试剂盒重复测定8次,分别计算不同浓度样本的平均值及SD值。
                    批内差: CV<10% 
                    批间差: CV<12% 
线性
在定值血清及血浆样本内加入适量的头蛋白(NOG),并倍比稀释成1:2,1:4,1:8,1:16的待测样本,线性范围即为稀释后样本中头蛋白(NOG)含量的测定值与理论值的比率。
| 样本 | 1:2 | 1:4 | 1:8 | 1:16 | 
| serum(n=5) | 83-98% | 80-92% | 78-98% | 97-105% | 
| EDTA plasma(n=5) | 91-99% | 93-105% | 81-88% | 88-98% | 
| heparin plasma(n=5) | 81-96% | 83-92% | 82-96% | 94-102% | 
稳定性
                    经测定,试剂盒在有效期内按推荐温度保存,其活性降低率小于5%。
                    为减小外部因素对试剂盒破坏前后检测值的影响,实验室的环境条件需尽量保持一致,尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。
                
实验流程
1. 实验前标准品、试剂及样本的准备;
                            2. 加样(标准品及样本)100µL,37°C孵育1小时;
                            3. 吸弃,加检测溶液A100µL,37°C孵育1小时;
                            4. 洗板3次;
                            5. 加检测溶液B100µL,37°C孵育30分钟;
                            6. 洗板5次;
                            7. 加TMB底物90µL,37°C孵育10-20分钟;
                            8. 加终止液50µL,立即450nm读数。
实验原理
将头蛋白(NOG)抗体包被于96孔微孔板中,制成固相载体,向微孔中分别加入标准品或标本,其中的头蛋白(NOG)与连接于固相载体上的抗体结合,然后加入生物素化的头蛋白(NOG)抗体,将未结合的生物素化抗体洗净后,加入HRP标记的亲和素,再次彻底洗涤后加入TMB底物显色。TMB在过氧化物酶的催化下转化成蓝色,并在酸的作用下转化成最终的黄色。颜色的深浅和样品中的头蛋白(NOG)呈正相关。用酶标仪在450nm波长下测定吸光度(O.D.值),计算样品浓度。
增值服务
相关产品
| 编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) | 
| APC130Hu01 | 头蛋白(NOG)活性蛋白 | Cell culture; Activity Assays. | 
| RPC130Hu01 | 头蛋白(NOG)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| RPC130Hu02 | 头蛋白(NOG)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| EPC130Hu61 | 头蛋白(NOG)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAC130Hu01 | 头蛋白(NOG)多克隆抗体 | WB; IHC; ICC; IP. | 
| PAC130Hu02 | 头蛋白(NOG)多克隆抗体 | WB; IHC; ICC; IP. | 
| LAC130Hu71 | 头蛋白(NOG)多克隆抗体(生物素标记) | WB; IHC; ICC. | 
| LAC130Hu81 | 头蛋白(NOG)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. | 
| MAC130Hu21 | 头蛋白(NOG)单克隆抗体 | WB | 
| MAC130Hu22 | 头蛋白(NOG)单克隆抗体 | WB; IHC | 
| MAC130Hu24 | 头蛋白(NOG)单克隆抗体 | WB; IHC | 
| MAC130Hu26 | 头蛋白(NOG)单克隆抗体 | WB; IHC | 
| FAC130Hu02 | 抗头蛋白(NOG)单克隆抗体 | FCM | 
| LAC130Hu76 | 头蛋白(NOG)单克隆抗体(生物素标记) | WB; IHC; ICC. | 
| SEC130Hu | 头蛋白(NOG)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| LMC130Hu | 头蛋白(NOG)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. | 
| PSC130Hu01 | 头蛋白(NOG)抗体对 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. | 
| KSC130Hu01 | 头蛋白(NOG)检测试剂盒DIY材料(酶联免疫吸附试验法) | Main materials for "Do It (ELISA Kit) Yourself". | 
参考文献
| 杂志 | 参考文献 | 
| Arthritis Rheumatol | Imbalance between BMP2 and Noggin induces abnormal osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis[PubMed: 26413886] | 
| Arthritis Rheumatol. | Imbalance Between Bone Morphogenetic Protein 2 and Noggin Induces Abnormal Osteogenic Differentiation of Mesenchymal Stem Cells in Ankylosing Spondylitis[Pubmed:26413886] | 
| Clin Exp Pharmacol Physiol. | Oxygen-glucose deprivation preconditioning protects neurons against oxygen-glucose deprivation/reperfusion induced injury via bone morphogenetic protein-7 mediated ERK, p38 and Smad signalling pathways.[Pubmed:26385023] | 
| European cells & materials | The BMP2 variant L51P restores the osteogenic differentiation of human mesenchymal stromal cells in the presence of intervertebral disc cells.[pubmed:28266688] | 
| Arthritis & Rheumatology | mbalance Between Bone Morphogenetic Protein 2 and Noggin Induces Abnormal OsteogenicDifferentiation of Mesenchymal Stem Cells in Ankylosing Spondylitis.[pubmed:26413886] | 
| Biotechnology and Applied Biochemistry | The BMP antagonist Noggin is produced by osteoblasts in response to the presence of prostate cancer cells.[pubmed:28981962] | 
| Heliyon | Efficient in vitro delivery of Noggin siRNA enhances osteoblastogenesis[pubmed:29167826] | 
| Journal of Cellular Biochemistry | Low‐intensity pulsed ultrasound promotes bone morphogenic protein 9‐induced osteogenesis and suppresses inhibitory effects of inflammatory cytokines on cellular …[Pubmed: 31006911] | 
| Aging Male | Effect of tadalafil on penile nitric oxide synthase and corporal smooth muscle in rats under dutasteride treatment[Pubmed: 32160825] | 
| J Reconstr Microsurg | Effect of Simvastatin Use in Free Tissue Transfer: An Experimental Study in a Rat Epigastric Free Flap Model[Pubmed: 31995818] | 
| Biochem Biophys Rep | Slow diffusion on the monolayer culture enhances auto/paracrine effects of Noggin in differentiation of human iPS cells induced by BMP[Pubmed:35005256] | 





